Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders: A network meta-analysis
- PMID: 31792285
- PMCID: PMC6889391
- DOI: 10.1038/s41598-019-54529-9
Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders: A network meta-analysis
Abstract
A systematic review and network-meta analysis (NMA) were performed to estimate significance of the anxiolytic effect of lavender essential oil taken as silexan capsules versus other comparators (i.e., placebo/paroxetine/lorazepam). The outcome of interest was Hamilton Anxiety Scale (HAMA). Weighted mean differences (WMD) were calculated to estimate the treatment effect at the confidence interval of 95%. League tables were generated using treatment effect, for all pairwise comparisons, where WMD < 0 favors the column-defining treatment. Five studies were identified with a total of 524 participants receiving treatment with silexan 80 mg and 121 participants taking silexan 160 mg. The NMA results indicated that consumption of silexan 160 mg resulted in higher decline of HAMA score [WMD -1.14 (-1.10, 3.39)] in comparison to silexan 80 mg, placebo [-2.20 (-4.64, 0.24)] and paroxetine [-1.24 (-5.34, 2.85)]. The effect of silexan 80 mg was observed to be same as that of paroxetine. Overall, silexan 160 mg was noticed to be a more efficient treatment giving significant decline in HAMA score across other comparators. However, no improvements in HAMA score was observed for the group receiving lorazepam 0.5 mg when compared to silexan 160 mg, silexan 80 mg, paroxetine 20 mg, and placebo.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.Int J Neuropsychopharmacol. 2014 Jun;17(6):859-69. doi: 10.1017/S1461145714000017. Epub 2014 Jan 23. Int J Neuropsychopharmacol. 2014. PMID: 24456909 Clinical Trial.
-
Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial.Eur Neuropsychopharmacol. 2015 Nov;25(11):1960-7. doi: 10.1016/j.euroneuro.2015.07.024. Epub 2015 Aug 7. Eur Neuropsychopharmacol. 2015. PMID: 26293583 Clinical Trial.
-
A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.Phytomedicine. 2010 Feb;17(2):94-9. doi: 10.1016/j.phymed.2009.10.006. Epub 2009 Dec 3. Phytomedicine. 2010. PMID: 19962288 Clinical Trial.
-
Silexan in anxiety disorders: Clinical data and pharmacological background.World J Biol Psychiatry. 2018 Sep;19(6):412-420. doi: 10.1080/15622975.2017.1331046. Epub 2017 Jun 19. World J Biol Psychiatry. 2018. PMID: 28511598 Review.
-
An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.Int J Psychiatry Clin Pract. 2013 Nov;17 Suppl 1:15-22. doi: 10.3109/13651501.2013.813555. Epub 2013 Aug 3. Int J Psychiatry Clin Pract. 2013. PMID: 23808618 Review.
Cited by
-
Recent progress of electrospun nanofibers as burning dressings.RSC Adv. 2024 May 1;14(20):14374-14391. doi: 10.1039/d4ra01514b. eCollection 2024 Apr 25. RSC Adv. 2024. PMID: 38694552 Free PMC article. Review.
-
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial.Eur Arch Psychiatry Clin Neurosci. 2024 Apr 1. doi: 10.1007/s00406-024-01783-2. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38558147
-
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials.Eur Psychiatry. 2024 Mar 1;67(1):e23. doi: 10.1192/j.eurpsy.2024.16. Eur Psychiatry. 2024. PMID: 38425206 Free PMC article. Review.
-
Development of a Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for Characterizing Linalool Oral Pharmacokinetics in Humans.Molecules. 2023 Sep 6;28(18):6457. doi: 10.3390/molecules28186457. Molecules. 2023. PMID: 37764231 Free PMC article.
-
Effectiveness of Aromatherapy in Early Palliative Care for Oncology Patients: Blind Controlled Study.Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2729-2739. doi: 10.31557/APJCP.2023.24.8.2729. Asian Pac J Cancer Prev. 2023. PMID: 37642059 Free PMC article. Clinical Trial.
References
-
- Alonso, J. & Lépine, J.-P. Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). The Journal of clinical psychiatry (2007). - PubMed